Loading...
Loading...
CRY| Name | Value |
|---|---|
| Revenues | 95.8M |
| Cost of Revenue | 34.8M |
| Gross Profit | 61.0M |
| Operating Expense | 56.6M |
| Operating I/L | 4.4M |
| Other Income/Expense | -5.7M |
| Interest Income | 0.4M |
| Pretax | -1.3M |
| Income Tax Expense | 1.0M |
| Net Income/Loss | -2.3M |
Artivion Inc. is a global manufacturer, processor, and distributor of medical devices and implantable human tissues. The company offers a wide range of products including BioGlue, On-X prosthetic heart valves, cardiac preservation services, vascular grafts, hemostats, and laser therapy products. Additionally, it provides stent graft systems for the treatment of aortic and peripheral vascular diseases, as well as synthetic vascular grafts and vascular preservation services. Artivion Inc. serves physicians, hospitals, and healthcare facilities, catering to cardiac, vascular, thoracic, and general surgeons. The company generates revenue through the sale of its medical devices, tissues, and related services.
